Olopatadine Hydrochloride
NDC 73581-712, Olopatadine Hydrochloride, solution, from YYBA CORP.
- Product NDC
- 73581-712
- Status
- Listed
- Labeler
- YYBA CORP
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA204812
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73581-712 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLOPATADINE HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73581-712-02 | 73581071202 | 2 BOTTLE in 1 CARTON (73581-712-02) / 2.5 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 73581-712 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73581-712 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73581-712. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.